First exercise period of Brighter Warrants TO3, October 11 to 25, 2017.

As part of our financing strategy and the agreement with L1 Capital, Brighter has on two occasions distributed free warrants to the company's shareholders to reduce dilution. October 11 to 25 is the first exercise period of Brighter Warrants TO3 during which holders of Warrants can subscribe for shares. The subscription price for the shares has been set at SEK 4.00 in accordance with §8, 11thparagraph in the TERMS OF SUBSCRIPTION OPTIONS IN BRIGHTER AB (PUBL) SERIES TO3 2017/2020 and the share issue price applied to the Private Placement to Recall Capital announced on August 7, 2017.

Holders of warrants TO3 who have their Warrants registered in custody at a bank or fund commissioner shall contact their bank or fund commissioner if they want to exercise the Warrants and subscribe for the corresponding shares. Exercise of the Warrants and subscription of shares for other holders of Warrants takes place through simultaneous payment and submittal of the registered application form, signed and submitted to the Company’s share agent no later than 16:00 CET on October 25, 2017.

The Company’s share agent is Eminova Fondkommission, which can be contacted by phone at 08-684 211 00 or by email at info@eminova.se. The subsequent five (5) exercise periods are:

  • 11 - 25 April 2018
  • 11 - 25 October 2018
  • 11 - 25 April 2019
  • 11 - 25 October 2019
  • 10 - 24 April 2020

For terms and conditions of the Warrants, please visit:

http://brighter.se/en/investors/documents/ .  

For more information, please contact:

Truls Sjöstedt, CEO     
Tel: +46 709 73 46 00     
Email: truls.sjostedt@brighter.se

Henrik Norström, COO     
Tel: +46 733 40 30 45     
Email: henrik.norstrom@brighter.se

About Brighter AB (publ)     
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

About Us

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first innovative tool Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

Subscribe

Documents & Links